Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China

BACKGROUND: To explore the efficacy and prognostic factors of different treatment modalities on anaplastic lymphoma kinase (ALK)+ non‐small cell lung cancer (NSCLC) patients with brain metastases (BMs). METHODS: A total of 86 patients were enrolled into the study. They were divided into two cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Xie, Mingying, Zhou, Zichao, Sheng, Jiamin, Yu, Xiaoqing, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870733/
https://www.ncbi.nlm.nih.gov/pubmed/36411716
http://dx.doi.org/10.1111/1759-7714.14739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870733/
https://www.ncbi.nlm.nih.gov/pubmed/36411716
http://dx.doi.org/10.1111/1759-7714.14739

Ejemplares similares